← Back to Patent Explorer
US4167569A Expired / Lapsed US ⏱️ 0.0 years remaining

Pyrimido[1,2-a ]benzimidazole derivatives

Assignee: Imperial Chemical Industries Ltd
•
Filing: 1977-11-23
•
Granted: 1979-09-11
•
Expires: 1997-11-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention concerns 3,4-dihydropyrimido [1,2-a]benzimidazole derivatives bearing one or more substituents at positions 6, 7, 8 or 9; processes for their preparation and manufacture; and pharmaceutical compositions thereof. The compounds inhibit the aggregation of blood-platelets and may be used in vivo, in the treatment or prophylaxis of thrombosis or occlusive vascular disease, or in vitro, in helping to stabilize preparations of blood platelets. Representative compounds of the invention are 7- and 8- acetyl-3,4-dihydropyrimido[1,2-a]benzimidazol-2(1H)-one.

Inventors

  • 👤 Stuart D. Mills

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 15:53
CPC Classifications
C; C07; C07D; C07D487/00; C07D487/02; C07D487/04; A; A61; A61P; A61P7/00; A61P7/02; C07D235/00; C07D235/02; C07D235/04; C07D235/24; C07D235/30; C07D491/00; C07D491/02; C07D491/04; C07D491/12; C07D491/14

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 209 words
A pyrimido[1,2-a]benzimidazole derivative of the formula: ##STR12## wherein R 1 is hydrogen, or a C 1-6 -alkyl radical; R 2 and R 3 , which may be the same or different, are hydrogen or C 1-6 -alkyl radicals; one or two of A 6 , A 7 , A 8 and A 9 , which may be the same or different, are halogen atoms, C 1-6 -alkyl, C 1-6 -alkoxy, C 2-6 -alkanoyl, 1-(hydroxy)-C 1-6 -alkyl, C 1-6 -alkylthio, C 1-6 -alkylsulphinyl or cyano radicals, or benzoyl radicals optionally substituted by a halogen atom, a C 1-6 -alkoxy or C 1-6 -alkyl radical, and the remainder of A 6 , A 7 , A 8 and A 9 are hydrogen; or an adjacent pair of A 6 , A 7 , A 8 and A 9 together constitute a C 1-6 -alkylenedioxy diradical, and the remainder of A 6 , A 7 , A 8 and A 9 is hydrogen; provided that when only one of A 6 , A 7 , A 8 and A 9 is a halogen atom, C 1-6 -alkyl or C 1-6 -alkoxy radical one of the remainder of A 6 , A 7 , A 8 and A 9 is other than hydrogen.
Claim 2
Dependent Claim 209 words
A pyrimido[1,2-a]benzimidazole derivative of the formula: ##STR12## wherein R 1 is hydrogen, or a C 1-6 -alkyl radical; R 2 and R 3 , which may be the same or different, are hydrogen or C 1-6 -alkyl radicals; one or two of A 6 , A 7 , A 8 and A 9 , which may be the same or different, are halogen atoms, C 1-6 -alkyl, C 1-6 -alkoxy, C 2-6 -alkanoyl, 1-(hydroxy)-C 1-6 -alkyl, C 1-6 -alkylthio, C 1-6 -alkylsulphinyl or cyano radicals, or benzoyl radicals optionally substituted by a halogen atom, a C 1-6 -alkoxy or C 1-6 -alkyl radical, and the remainder of A 6 , A 7 , A 8 and A 9 are hydrogen; or an adjacent pair of A 6 , A 7 , A 8 and A 9 together constitute a C 1-6 -alkylenedioxy diradical, and the remainder of A 6 , A 7 , A 8 and A 9 is hydrogen; provided that when only one of A 6 , A 7 , A 8 and A 9 is a halogen atom, C 1-6 -alkyl or C 1-6 -alkoxy radical one of the remainder of A 6 , A 7 , A 8 and A 9 is other than hydrogen.
Claim 3
Dependent Claim 173 words
A compound as claimed in claim 1 wherein R 1 is hydrogen or a methyl or ethyl radical; R 2 and R 3 , which may be the same or different, are hydrogen or methyl or ethyl radicals; one or two of A 6 , A 7 , A 8 and A 9 , which may be the same or different, are fluorine, chlorine or bromine atoms, methyl, ethyl, propyl, methoxy, ethoxy, i-propoxy, acetyl, propionyl, butyryl, hyroxymethyl, 1-hydroxyethyl, 1-hydroxypropyl, 1-hydroxybutyl, methylthio, ethylthio, methylsulphinyl, ethylsulphinyl or cyano radicals, or benzoyl radicals optionally substituted by a fluorine, chlorine or bromine atom, or by a methyl or methoxy radical and the remainder of A 6 , A 7 , A 8 and A 9 are hydrogen; or an adjacent pair of A 6 , A 7 , A 8 and A 9 together constitute a methylenedioxy or isopropylidenedioxy radical, and the remainder is of A 6 , A 7 , A 8 and A 9 is hydrogen, or is an atom or radical as defined above.
Claim 4
Dependent Claim 103 words
A compound as claimed in claim 1 wherein two of A 6 , A 7 , A 8 and A 9 constitute a 6,7-, 7,8-, 8,9- or 6,9- dimethyl radical, a 7,8-dichloro, 7-chloro-8-methyl, 7-methyl-8-chloro, 7,8-dimethoxy, 7,8-diisopropoxy or a 7,8-methylenedioxy radical, and the remainder of A 6 , A 7 , A 8 and A 9 are hydrogen; or wherein one of A 6 , A 7 , A 8 and A 9 is a 7- or 8-acetyl, -butyryl, -benzoyl, -(p-chloro)benzoyl, -methylthio, -ethylthio, -ethylsulphinyl, -cyano or-[1-(hydroxy)ethyl] radical, and the remainder of A 6 , A 7 , A 8 and A 9 are hydrogen.
Claim 5
Dependent Claim 74 words
A compound as claimed in claim 1 wherein R 1 is hydrogen, R 2 and R 3 , which may be the same or different, are hydrogen or methyl radicals, at least two of A 6 , A 7 , A 8 and A 9 are hydrogen, and the remainder of A 6 , A 7 , A 8 and A 9 have any of the values other than hydrogen defined in claim 1.
Claim 6
Dependent Claim 69 words
A compound as claimed in claim 1, wherein R 1 is hydrogen, R 2 and R 3 , which may be the same or different, are hydrogen or methyl radicals, A 7 and one of A 6 , A 8 and A 9 have any of the values other than hydrogen defined in claim 1 and the remainder of A 6 , A 8 and A 9 is hydrogen.
Claim 7
Dependent Claim 69 words
A compound as claimed in claim 1, wherein R 1 is hydrogen, R 2 and R 3 , which may be the same or different, are hydrogen or methyl radicals, A 8 and one of A 6 , A 7 and A 9 have any of the values other than hydrogen defined in claim 1, and the remainder of A 6 , A 7 and A 9 are hydrogen.
Claim 8
Dependent Claim 65 words
A compound as claimed in claim 1 wherein R 1 is hydrogen, R 2 and R 3 , which may be the same or different, are hydrogen or methyl radicals, A 7 and/or A 8 have any of the values other than hydrogen defined in claim 1, and the remainder of A 6 , A 7 , and A 8 and A 9 are hydrogen.
Claim 9
Dependent Claim 21 words
A compound as claimed in claim 1 wherein A 7 or A 8 is a cyano, acetyl, 1-(hydroxy)ethyl or benzoyl radical.
Claim 10
Dependent Claim 25 words
A compound as claimed in claim 1 wherein A 7 and A 8 together constitute a methylenedioxy diradical, or are methoxy, ethoxy or isopropoxy radicals.
Claim 11
Dependent Claim 15 words
The compounds 7-acetyl-, 8-acetyl-, 7-benzoyl-, 8-benzoyl-, 7-cyano-, 8-cyano-, 7,8-di-isopropoxy- and 7,8-methylenedioxy-3,4-dihydropyrimido[1,2-a]benzimidazol-2-(1H)-one, and 7-benzoyl-, and 8-benzoyl-4-methyl-3,4-dihydropyrimido-[1,2-a]benzimidazol-2(1H)-one.
Claim 12
Dependent Claim 15 words
The compounds 7-acetyl-, 8-acetyl-, 7-benzoyl-, 8-benzoyl-, 7-cyano-, 8-cyano-, 7,8-di-isopropoxy- and 7,8-methylenedioxy-3,4-dihydropyrimido[1,2-a]benzimidazol-2-(1H)-one, and 7-benzoyl-, and 8-benzoyl-4-methyl-3,4-dihydropyrimido-[1,2-a]benzimidazol-2(1H)-one.
Claim 13
Dependent Claim 36 words
A pharmaceutical composition for use in inhibiting the aggregation of blood platelets which comprises an effective amount of a compound of formula I as claimed in claim 1 together with a pharmaceutically acceptable diluent or carrier.
Claim 14
Dependent Claim 20 words
A composition as claimed in claim 11 which is in the form of a tablet, capsule, aqueous or oily suspension.
Claim 15
Dependent Claim 35 words
A method of inhibiting the aggregation of blood platelets in an animal requiring such treatment which comprises administering to said animal an effective amount of a compound of formula I as claimed in claim 1.
Claim 16
Dependent Claim 34 words
A method of stabilising an in vitro preparation of blood platelets which comprises adding to said preparation a blood platelet aggregation inhibitory amount of a compound of formula I as claimed in claim 1.
Claim 17
Dependent Claim 3 words
The compound 8-cyano-3,4-dihydropyrimido[1,2-a]benzimidazol-2(1H)-one.
Claim 18
Dependent Claim 3 words
The compound 8-cyano-3,4-dihydropyrimido[1,2-a]benzimidazol-2(1H)-one.

References Cited (Backward Citations)

US3468888A Cited
US3988340A Cited
US4109091A Cited
US4109087A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1982-09-10 1983-03-12 1983-09-11 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1986-09-10 1987-03-12 1987-09-11 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1990-09-10 1991-03-12 1991-09-11 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag